不同剂量西普罗对心脏手术患者麻醉诱导期间血液动力学的影响:一项随机,双盲,受控研究
Yingting Zhou1, ZiYou Liu1, QianQian Li1
1Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.
Drug design, development and therapy
|March 18, 2025
概括
低剂量西普罗 (0.2毫克/千克) 在心脏手术患者中显示出最小的血液动力学影响,与埃托米达相比,减少了对北上腺素的需求. 这一发现表明,西普罗是一种更安全的麻醉选择.
科学领域:
- 麻醉学 麻醉学
- 心血管外科心血管外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏手术需要仔细的麻醉管理,以保持血液动力学稳定性.
- 埃托米达是常用的,但它的血液动力学效应可能是显著的.
- 西普罗是一种新的麻醉剂,具有潜在的血液动力学优势.
研究的目的:
- 在心脏手术患者中,比较不同剂量西普罗与埃托米达的血液动力学效应.
- 为了评估对心率,血压和心脏输出量的影响.
- 评估对血管活性药物支持的需要.
主要方法:
- 一项随机对照试验,涉及209名接受心脏手术的患者.
- 四组:埃托米达 (0.2毫克/公斤) 和西普罗 (0.2,0.3,0.4毫克/公斤).
- 在整个手术过程中,血动力学参数 (MAP,HR,CO,SV,SVR) 和双光谱指数都被监测. 记录了低血压,心肌梗塞和血管活性药物剂量的发生率.
主要成果:
- 所有麻醉剂都导致HR,MAP,SV和CO的减少.
- 与埃托米达相比,0.2毫克/公斤的西普罗显示出与埃托米达相比,对北上腺素的需求明显较低.
- 较高剂量的西普罗 (0.3,0.4毫克/千克) 导致CO和SV的减少较大,相比于埃托米达和0.2毫克/千克的西普罗.
结论:
- 在心脏手术患者中,0.2 mg/kg的西普罗对血液动力学影响最小.
- 这一剂量西普罗可能会减少对血管活性药物的需要,如诺拉皮内林.
- 0.2 mg/kg的西普罗似乎是心脏手术中血液动力学上有利的麻醉选择.
相关概念视频
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
37
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
37
Heart Failure Drugs: Inotropic Agents
479
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
479
General Anesthesia: Overview
183
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
183
Stages of General Anesthesia
336
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
336
Parenteral Anesthetics: Overview
91
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
91
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K


